NAMUH, Ginkgo Bioworks Ink Partnership To Develop Functional Oligosaccharides

RTTNews | 842 일 전
NAMUH, Ginkgo Bioworks Ink Partnership To Develop Functional Oligosaccharides

(RTTNews) - Infant nutrition company NAMUH and Ginkgo Bioworks Holdings, Inc. (DNA) announced Wednesday a multi-product collaboration to develop functional oligosaccharides that are structurally identical to those found in human breast milk.

NAMUH's mission is to create complete infant formula products substantially comparable to human breast milk, down to the molecular level.

Human Milk Oligosaccharides (HMOs) are essential fiber-like nutrients unique to human milk that provide an important energy source to beneficial gut bacteria in infants.

Despite being the third most abundant component in human milk, HMOs are currently a small component in infant formulas, if present at all.

Currently, NAMUH's proprietary technology provides for a cost-effective source of a family of HMOs via yeast fermentation.

Through this partnership, NAMUH will leverage Ginkgo's expertise in yeast strain engineering and fermentation process development to enable the production of various HMOs through yeast fermentation and work to unlock the possibility of making infant formula nutritionally robust and much closer to human breast milk.

read more
Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
RTTNews | 393 일 전
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.
RTTNews | 485 일 전
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
RTTNews | 1019 일 전
China Exports Growth Beats Expectations; Imports Drop At Slower Pace

China Exports Growth Beats Expectations; Imports Drop At Slower Pace

China's exports grew more than expected in April despite the sharp contraction in shipments to the United States following the trade tariff hikes, while imports decreased at a meager pace, official data revealed on Friday. Exports advanced 8.1 percent on a yearly basis in April, customs data showed. While the growth rate slowed from 12.4 percent in March.
RTTNews | 1 시간 3 분 전
NZ Dollar Falls After China Trade Data

NZ Dollar Falls After China Trade Data

The New Zealand dollar weakened against other major currencies in the Asian session on Friday, as China's most recent trade figures indicated a slowing down of outside demand.
RTTNews | 1 시간 20 분 전